Emerging role of PET in the diagnosis and staging of lung cancer
G Coates, SJ Skehan - Canadian Respiratory Journal, 1999 - Wiley Online Library
Positron emission tomography (PET) with 18F‐fluoro‐2‐deoxyglucose (FDG) has recently
emerged as a practical and useful imaging modality in patients with lung cancer. Malignant …
emerged as a practical and useful imaging modality in patients with lung cancer. Malignant …
Lung cancer and positron emission tomography with fluorodeoxyglucose
EM Marom, JJ Erasmus, EF Patz Jr - Lung Cancer, 2000 - Elsevier
Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-d-glucose
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
(FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been …
Positron emission tomography in lung cancer
H Nomori, Y Ohba, K Yoshimoto, H Shibata… - General thoracic and …, 2009 - Springer
Recent advances in positron emission tomography (PET) with 2-deoxy-2-fluoro [F-18]-d-
glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the …
glucose (FDG) has enabled not only the diagnosis and staging of lung cancer but also the …
The future in diagnosis and staging of lung cancer: positron emission tomography
BM Fischer, J Mortensen - Respiration, 2006 - karger.com
Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …
Imaging in lung cancer: positron emission tomography scan
JF Vansteenkiste - European Respiratory Journal, 2002 - Eur Respiratory Soc
In the past 5 yrs, positron emission tomography (PET), usually used with 18 F‐fluoro‐2‐
deoxy-glucose (FDG), has become an important imaging modality in lung cancer patients …
deoxy-glucose (FDG), has become an important imaging modality in lung cancer patients …
The use of FDG-PET scanning in lung cancer
K Sönmezoğlu - Tuberkuloz ve Toraks, 2005 - europepmc.org
Positron emission tomography (PET) imaging with fluorodeoxyglucose (FDG) is a very
useful imaging modality that significantly contributes to the diagnosis and staging in patients …
useful imaging modality that significantly contributes to the diagnosis and staging in patients …
Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography
T Bury, A Dowlati, P Paulus, R Hustinx… - European journal of …, 1996 - Springer
Positron emission tomography (PET) using fluorine-18 deoxyglucose (FDG), showing
increased FDG uptake and retention in malignant cells, has been proven useful to …
increased FDG uptake and retention in malignant cells, has been proven useful to …
Diagnosis of lung cancer. Role of PET/CT fusion scan in lung cancer
B Melloni, V Gazaille, F Bertin, S Gaillard… - Revue des maladies …, 2006 - europepmc.org
Whole-body positron emission tomography (PET) with radiolabeled [18F]-fluoro-2-deoxy-D-
glucose (18FDG) plays an important role in the diagnosis, staging, and management of lung …
glucose (18FDG) plays an important role in the diagnosis, staging, and management of lung …
Contribution of PET using FDG in the diagnosis of lung cancer--first results
R Rubinstein, R Breuer, R Chisin - Harefuah, 2001 - europepmc.org
Positron emission tomography (PET), when used with F-18 fluoro-deoxyglucose (FDG),
contributes to the evaluation of patients with lung cancer. This technique of imaging detects …
contributes to the evaluation of patients with lung cancer. This technique of imaging detects …
Use of positron emission tomography to diagnose and stage lung cancer
WJ Scott, NA Dewan - Clinical Pulmonary Medicine, 1999 - journals.lww.com
Lung cancer is the leading cause of death from cancer in both men and women. The
presence of distant metastases or metastases to mediastinal lymph nodes has a significant …
presence of distant metastases or metastases to mediastinal lymph nodes has a significant …